Background-Peroxisome proliferator-activated receptors (PPARs) are transcription factors belonging to the nuclear receptor superfamily. PPAR␥ mRNA is present in cardiac myocytes; however, whether PPAR␥ affects cardiac hypertrophy remains unknown. Methods and Results-We investigated the effects of PPAR␥ activators on cardiac hypertrophy in neonatal rat cardiac myocytes. Cyclic 4% biaxial mechanical strain caused enlargement of cardiac myocytes (1.3-fold versus control, PϽ0.0001), but the PPAR␥ activators troglitazone and 15-deoxy-⌬ 12-14 -prostaglandin J 2 (15d-PGJ 2 ) (10 mol/L) inhibited this effect (troglitazone, Ϫ72%, PϽ0.0005; 15d-PGJ 2 , Ϫ88%, PϽ0.0002). Total cell protein was increased by mechanical strain (control, 164.3 g/dish; strain, 265.5, PϽ0.0002), and this effect was inhibited by troglitazone and 15d-PGJ 2 (troglitazone, Ϫ61%, PϽ0.005; 15d-PGJ 2 , Ϫ72%, PϽ0.001).
I ncreased cardiac work load leads to cardiac hypertrophy, an independent risk factor of cardiac morbidity and mortality that can progress to clinical heart failure. 1 Studies performed in animal models of hypertrophy and cardiac myocytes have shown that mechanical strain and other factors, including norepinephrine, angiotensin II, endothelin-1, insulin-like growth factor-I, interleukin-1␤ (IL-1␤), tumor necrosis factor-␣, leukemia inhibitory factor, and cardiotropin-1 are potential stimuli for myocyte hypertrophy. 2 Mechanical overload is a common clinical stimulus of cardiac hypertrophy, and deformation of cardiac myocytes increases specific genes, protein synthesis, and cell size.
Peroxisome proliferator-activated receptors (PPARs) are a family of 3 nuclear hormone receptors, PPAR␣, PPAR␦, and PPAR␥. 3 PPAR␥ is activated by the natural ligand 15-deoxy-⌬ 12,14 -prostaglandin J 2 (15d-PGJ 2 ) 4 as well as the synthetic ligand thiazolidinedione (troglitazone). 5 The thiazolidinedio-nes decrease blood pressure in a hypertensive rat model 6 and inhibit neointimal formation of balloon-injured vessels in rats. 7 Recently, Takano et al 8 demonstrated that PPAR activators inhibit tumor necrosis factor-␣ expression at the transcriptional level in part by preventing nuclear factor (NF)-B activity in cardiac myocytes. Barger et al 9 reported that PPAR␣ is deactivated during cardiac hypertrophic growth, leading to diminished capacity for myocardial lipid and energy homeostasis. However, it remains unclear whether PPAR␥ participates in cardiac hypertrophy in cardiac myocytes.
In this study, we investigated the effects of PPAR␥ activators on cardiac hypertrophy in cultured neonatal rat cardiac myocytes. We found that PPAR␥ activators inhibit cardiomyocyte hypertrophy induced by mechanical strain as well as angiotensin II or phenylephrine in neonatal rat cardiac myocytes. These results suggest that the PPAR␥ pathway participates in cardiac hypertrophy. 
Methods

Materials
Culture of Neonatal Rat Ventricular Myocytes
Neonatal rat ventricular myocytes (NRVM) from 1-day-old Sprague-Dawley rats were isolated by previously described methods. 10 The ventricles were excised from the rat, cut into several pieces, and incubated overnight at 4°C in 1 mg/mL of 1:300 trypsin in Hanks' balanced salt solution (HBSS, Life Technologies, Inc). The ventricular tissue was then digested with 1 mg/mL of collagenase type II (239 U/mg, Worthington Biochemicals) in HBSS, centrifuged twice at 50g to remove less dense cells such fibroblasts, and then plated. The cells were cultured at 37°C, 5% CO 2 in DMEM (BioWhittaker) containing 7% FCS, 50 U/mL penicillin, and 50 g/mL streptomycin (PS).
This investigation was performed according to the Guide for the Care and Use of Laboratory Animals published by US National Institutes of Health (NIH publication No. 85-23, revised 1996).
Mechanical Strain Device and Preparation of Cells
Mechanical deformation was applied to a thin and transparent membrane on which cells were cultured, an approach that produces controlled cellular strain as well as visualization of cells. 11 For the preparation of NRVM to be subjected to mechanical strain, autoclaved membrane dishes were coated with 2 g/mL of fibronectin in 13 mL of HBSS for 6 to 12 hours at 4°C and then washed twice with 10 mL of PBS. NRVM were plated on the coated membrane dish at a density of 2 000 000 cells/dish in 13 mL of DMEM containing 7% FCS and incubated 48 hours. NRVM were then made quiescent by washing with 10 mL of HBSS twice and incubating with 10 mL of DMEM containing 1% insulin, transferrin, selenium media supplement (ITS; Sigma), and PS. All experiments were performed on NRVM that had been serum-starved for 24 hours.
Cardiac Myocyte Surface Area
The myocyte surface area was measured by the method of Simpson. 12 Cell images captured by video camera (Nikon) were traced and analyzed with NIH Image 1.56. The area was then doubled to account for the surface portion in contact with the dish. All cells from randomly selected fields in 2 or 3 dishes were examined for each condition. We measured 100 cells in each condition.
Incorporation of [ 3 H]Leucine
NRVM were subjected to 0% or 4% cyclic mechanical strain in the presence or absence of PPAR␥ activators with 1.0 Ci/mL [ 3 H]leucine for 24 hours. The medium was aspirated and the cells were washed twice with ice-cold PBS and once with 10% trichloroacetic acid (TCA; Sigma) and fixed for 45 minutes at 4°C with 10% TCA. After washing twice with cold 95% ethanol, radioactivity incorporated into the TCA-precipitable material was determined by liquid scintillation counting after solubilization in 0.15N NaOH.
Protein Content
NRVM were subjected to 0% or 4% cyclic mechanical strain in the presence or absence of PPAR␥ activators for 48 hours. The cells were washed twice with PBS and then treated with 10% TCA as described above. The precipitates were dissolved in NaOH (0.15N).
The protein content was measured by the Bio-Rad DC protein assay (Bio-Rad Laboratories).
Northern Analysis
Total RNA was isolated by the guanidinium thiocyanate and phenol chloroform method. 13 Purified RNA (1 g) was used for the synthesis of cDNA with a reverse-transcriptase polymerase chain reaction system (Stratagene). Synthesis of the cDNAs was performed by polymerase chain reaction with Taq polymerase (Perkin-Elmer). The primer set for the synthesis of the 387-base pair rat brain natriuretic peptide (BNP) cDNA probe contained the 5Ј-TTTTCCTTAATCTGTCGCCG-3Ј sense and 5Ј-AGAGCTGGGG-AAAGAAGAGC-3Ј antisense oligonucleotides. This rat BNP cDNA was radiolabeled by the random priming method with [␣-32 P]dCTP and the Klenow fragment of DNA polymerase (Stratagene). For Northern blotting, 15 g of total RNA was loaded on a 1.0% formaldehyde gel, transferred to a nylon membrane (Stratagene), and UV cross-linked with a UV Stratalinker (Stratagene). The probe was hybridized with QuikHyb solution (Stratagene) at 68°C for 1 hour. Normalization of RNA for equal loading was carried out by rehybridizing the blots with a glyceraldehyde-3 phosphate dehydrogenase (GAPDH) cDNA probe (Clontech).
Electrophoretic Mobility Shift Assay
Nuclear extracts from cardiac myocytes were prepared by 3 washes of the cell layer in ice-cold PBS; the cells were scraped off the tissue culture dish, resuspended, and sedimented by centrifugation. The cell pellet was lysed in a buffer composed of 20 mmol/L HEPES-KOH (pH 7.9), 0.35 mmol/L NaCl, 20% glycerol, 1% NP-40, 1 mmol/L MgCl 2 , 0.5 mmol/L EDTA, 0.5 mmol/L EGTA, 10 g/mL leupeptin, 0.5 mmol/L dithiothreitol, and 0.2 mmol/L PMSF by incubation on ice for 30 minutes. After centrifugation, the supernatant containing the protein fraction was frozen at Ϫ80°C. For electrophoretic mobility shift assays, a double-strand oligonucleotide representing the consensus sequence for NF-B binding (5Ј-TCAACAGAGGG-GACTTTCCGAGGCCA-3Ј) was labeled with [␥-32 P]dATP by use of T 4 polynucleotide kinase. The labeled probe was separated from unincorporated nucleotide with a Sephadex G-50 column (Amersham Pharmacia Biotech KK). Ten micrograms of nuclear extract was incubated in 10 L of binding buffer containing 5 mmol/L MgCl 2 , 2.5 mmol/L EDTA, 2.5 mmol/L dithiothreitol, 250 mmol/L NaCl, 50 mmol/L Tris-HCl (pH 7.5), 0.25 mg/mL poly(dI-dC), and 20% glycerol for 10 minutes at room temperature. 32 P-labeled oligonucleotide probe (50 000 to 200 000 cpm) was then added, and the reaction mixture was incubated for 20 minutes at room temperature. Immediately after binding, the protein/DNA complexes were separated from unbound oligonucleotide by electrophoresis on a native 5% polyacrylamide gel in Tris-HCl-EDTA buffer. Autoradiography was performed with the dried gels and Hyperfilm (Amersham Pharmacia Biotech KK). For testing of specificity of NF-B/ DNA binding, antibodies (Santa Cruz Biotechnology Inc) against the p65 subunits of NF-B were added to the proteins, resulting in further retardation of electrophoretic mobility, or a 160-fold molar excess of unlabeled oligonucleotide was added to the binding reaction, leading to a decrease in NF-B-bound radioactivity.
Statistical Analysis
Data are expressed as meanϮ1 SD. Statistical analysis was performed by 1-way ANOVA, with comparison of different groups by Fisher's protected least significantly difference test. A value of PϽ0.05 was considered significant.
Results
Inhibitory Effects of PPAR␥ Activators on Myocyte Hypertrophy Induced by Mechanical Strain
We initially investigated whether myocyte hypertrophy induced by mechanical strain was affected by the PPAR␥ activators troglitazone and 15d-PGJ 2 . As shown in Figures 1 and 2, cyclic 4% biaxial mechanical strain at a frequency of 1 Hz significantly caused enlargement of cardiac myocytes (1.3Ϯ0.1-fold versus control, nϭ100 cells, PϽ0.0001). The PPAR␥ activators troglitazone and 15d-PGJ 2 (both 10 mol/L) significantly inhibited this effect (troglitazone, Ϫ72%, nϭ100 cells, PϽ0.0005; 15d-PGJ 2 , Ϫ88%, nϭ100 cells, PϽ0.0002). PPAR␥ ligands (10 mol/L) by themselves did not affect the myocyte surface area (nϭ100 cells, PϭNS, Figure 2 ).
Inhibitory Effects of PPAR␥ Activators on Mechanically Induced Increase in Protein Content
Total cell protein was also significantly increased by 4% cyclic mechanical strain (control, 164.3Ϯ11.9 g/dish, nϭ4; strain, 265.5Ϯ18.0, PϽ0.0002), and this was inhibited by troglitazone and 15d-PGJ 2 (10 mol/L) (troglitazone, 204.0Ϯ14.5 g/dish, Ϫ61%, nϭ4, PϽ0.005; 15d-PGJ 2 , 192.3Ϯ14.7, Ϫ72%, nϭ4, PϽ0.001). PPAR␥ activators (10 mol/L) by themselves did not affect basal levels of total cell protein (nϭ4, PϭNS, Figure 3 ). Inhibitory effects of PPAR␥ activators on myocyte enlargement induced by mechanical strain. Myocytes were exposed for 48 hours to 0% (open bars) or 4% (closed bars) cyclic mechanical strain (1 Hz) in the presence or absence of PPAR␥ activators (10 mol/L). PPAR␥ activators were applied to myocytes 30 minutes before mechanical strain. Cell size results are expressed as relative surface area standardized to mean surface area of control cells in each experiment. Bar graphs with error bars represent meanϮSD (nϭ100). *PϽ0.0001 vs control; †PϽ0.0005 vs exposed to strain; ‡PϽ0.0002 vs exposed to strain. . Effects of PPAR␥ activators on protein synthesis induced by mechanical strain. Myocytes were exposed to 0% (open bars) or 4% (closed bars) cyclic mechanical strain (1 Hz) in the presence or absence of PPAR␥ activators (10 mol/L) with 1.0 Ci/mL [ 3 H]leucine for 24 hours. PPAR␥ activators were applied to myocytes 30 minutes before experiments. Protein synthesis results are expressed as relative cpm/dish standardized to mean cpm of control cells in each experiment. Bar graphs with error bars represent meanϮSD (nϭ4). *PϽ0.002 vs control; †PϽ0.05 vs exposed to strain; ‡PϽ0.02 vs exposed to strain; §PϽ0.01 vs exposed to strain; ¶PϽ0.005 vs exposed to strain. B, Myocytes subjected to 4% cyclic mechanical strain. C, Myocytes subjected to 4% cyclic mechanical strain in the presence of troglitazone (10 mol/L). D, Myocytes subjected to 4% cyclic mechanical strain in the presence of 15d-PGJ 2 (10 mol/L). NRVM were plated on 2 g/mL of fibronectin in DMEM containing 7% FCS for 24 hours. After serum deprivation for 24 hours, myocytes were exposed for 48 hours to 0% or 4% cyclic mechanical strain (1 Hz) in the presence or absence of PPAR␥ activators. PPAR␥ activators were applied to myocytes 30 minutes before mechanical strain. Barϭ100 m.
Figure 3.
Inhibitory effects of PPAR␥ activators on mechanically induced increase in protein content. Myocytes were exposed for 48 hours to 0% (open bars) or 4% (closed bars) cyclic mechanical strain (1 Hz) in the presence or absence of PPAR␥ activators (10 mol/L). Protein content was then measured. PPAR␥ activators were applied to myocytes 30 minutes before mechanical strain. Bar graphs with error bars represent meanϮSD (nϭ4). *PϽ0.0002 vs control; †PϽ0.005 vs exposed to strain;
‡PϽ0.001 vs exposed to strain.
Inhibitory Effects of PPAR␥ Activators on [ 3 H]Leucine Incorporation Induced by Mechanical Strain
As shown in Figure 4 , [ 3 H]leucine uptake was significantly increased by 4% mechanical strain (1.9Ϯ0.2-fold versus control, nϭ4, PϽ0.002, Figure 4 ), and this was inhibited by troglitazone and 15d-PGJ 2 in a concentration-dependent manner (0.1 to 10 mol/L) (troglitazone, Ϫ52% at 10 mol/L, nϭ4, PϽ0.01; 15d-PGJ 2 , Ϫ70% at 10 mol/L, nϭ4, PϽ0.005). PPAR␥ activators (10 mol/L) by themselves did not affect basal levels of [ 3 H]leucine incorporation. (nϭ4, PϭNS, Figure 4 ).
Inhibitory Effects of PPAR␥ Activators on [ 3 H]Leucine Incorporation Induced by Angiotensin II and Phenylephrine
Next, we investigated whether the blocking effects of PPAR␥ activators are also observed with hypertrophic growthinduced angiotensin II or phenylephrine. [ 3 H]Leucine uptake was increased by angiotensin II (0.1 mol/L) (1.6Ϯ0.2-fold versus control, nϭ4, PϽ0.01, Figure 5A ) or phenylephrine (50 mol/L) (1.7Ϯ0.2-fold versus control, nϭ4, PϽ0.005, Figure 5B ), and this increase was inhibited by troglitazone and 15d-PGJ 2 in a concentration-dependent manner (0.1 to 10 mol/L) (angiotensin II: troglitazone, Ϫ60% at 10 mol/L, nϭ4, PϽ0.01; 15d-PGJ 2 , Ϫ74% at 10 mol/L, nϭ4, PϽ0.005; phenylephrine: troglitazone, Ϫ56% at 10 mol/L, nϭ4, PϽ0.02; 15d-PGJ 2 , Ϫ67% at 10 mol/L, nϭ4, PϽ0.01).
Effects of PPAR␥ Activators on BNP mRNA Expression Induced by Mechanical Strain
We investigated whether the PPAR␥ ligands affect the expression of BNP mRNA, a marker for cardiac hypertrophy 14 that is induced by mechanical strain. As shown in Figure 6 , 4% cyclic mechanical strain induced mRNA ex-pression for BNP in cardiac myocytes, but both PPAR␥ activators, troglitazone, and 15d-PGJ 2 (10 mol/L), inhibited this effect. PPAR␥ activators (10 mol/L) by themselves did not affect BNP mRNA expression.
Effects of PPAR␥ Activators on NF-B Activation by Mechanical Strain
Because activation of NF-B may participate in cardiac hypertrophy or remodeling, 15 electrophoretic mobility shift assays were performed with the use of radiolabeled oligonucleotides. As shown in Figure 7 , 4% mechanical strain caused the activation of NF-B. The addition of IL-1␤ (10 ng/mL) also induced the activation of NF-B in the absence of strain. Both PPAR␥ activators (10 mol/L), troglitazone, and 15d-PGJ 2 completely inhibited the activation of NF-B induced by mechanical strain. The shifted complexes were specific for NF-B because they were supershifted in the presence of antibody to the NF-B subunit and disappeared with excess unlabeled oligonucleotide. In addition, we investigated whether NF-B pathway participates in cardiac hypertrophy. Pyrrolidine dithiocarbamate, an inhibitor of NF-B activation, inhibited an increase in [ 3 H]leucine uptake induced by 4% mechanical strain (Ϫ50% at 100 mol/L, nϭ4, PϽ0.05, Figure 8 ). These findings suggest that the NF-B pathway may be involved in the inhibitory effects of PPAR␥ activators on cardiac hypertrophy in cardiac myocytes.
Discussion
In the present study, PPAR␥ activators such as troglitazone and 15d-PGJ 2 inhibited increases in cell size, protein content, protein synthesis and BNP mRNA expression, and the activation of NF-B by cyclic mechanical strain in cardiac myocytes. In addition, PPAR␥ activators inhibited an increase in protein synthesis induced by angiotensin II or phenylephrine. These findings suggest that the PPAR␥ pathway may regulate the molecular response to hypertrophic stimuli in the heart. PPAR␥ is expressed predominantly in adipose tissue, whereas PPAR␣ is present in liver, kidney, and muscle. 16 Previous studies 16, 17 have shown that PPAR␣ is expressed in variable amounts between individuals, whereas PPAR␥ is expressed at a low level in adult rat or adult human heart. Recently, it was reported that expressions of PPAR␣ and PPAR␥ were similar in neonatal rat cardiac myocytes. 8 PPAR␥ can be activated by a number of ligands including thiazolidinedione (troglitazone), 15d-PGJ 2 , PGJ 2 , oxidized LDL, 13-oxidized octadecadienoic acid, and nonsteroidal anti-inflammatory drugs. 18 PPARs act as transcription factors on ligand-induced heterodimerization with the common nuclear receptor binding partner, the retinoid X receptor (RXR). When combined as a PPAR:RXR heterodimer, PPAR ligands and 9-cis retinoic acid can act synergistically on PPAR responses. Different dimers of RXR induce specific responses by binding highly specific sequences in the promoter regions of the various genes. In the present study, PPAR␥ ligands troglitazone and 15d-PGJ 2 inhibited increases in cell size as well as protein content and protein synthesis induced by mechanical strain, angiotensin II, or phenylephrine in rat cardiac myocytes. These findings suggest that PPAR␥ pathway may play an important role in cardiac hypertrophy.
A greater understanding of the transcriptional regulation that directs cardiac hypertrophy will be critical for implementing novel and more effective therapeutic strategies in the future. In the PPAR␥-dependent pathway, ligand-activated PPAR␥ positively regulates gene expression through binding to specific DNA sequence (PPAR response element) 3 or inhibiting other gene expression in part through antagonism of the activities of other transcription factors, such as NF-B. 19 In the present study, both PPAR␥ activators completely inhibited the activation of NF-B by mechanical strain, and pyrrolidine dithiocarbamate, an inhibitor of NF-B activation, partially but significantly inhibited the hypertrophic response induced by 4% mechanical strain. These findings suggest that PPAR␥ activators may regulate cardiomyocyte hypertrophy at least partially through the NF-B pathway. However, we cannot exclude a role for NF-B as a mechanism, because pyrrolidine dithiocarbamate has many effects that could affect hypertrophy. In addition, further experiments will be necessary to investigate whether PPAR␥ activators affect other transcription factors such as signal transducers and activators of transcription (STAT) and nuclear factor of activated T cells-3 (NF-AT3). Figure 7 . Electrophoretic mobility shift assay showing effects of PPAR␥ activators on activation of NF-B by mechanical strain. Myocytes were exposed for 1 hour to 0% or 4% cyclic mechanical strain (1 Hz) in the presence or absence of PPAR␥ activators (10 mol/L) or IL-1␤ (10 ng/mL). PPAR␥ activators were applied to myocytes 30 minutes before mechanical strain. Nuclear extracts (10 g) from cardiac myocytes were incubated with 32 P-labeled NF-B consensus oligonucleotide. Binding of activated NF-B to oligonucleotide was visualized by autography after separation by nondenaturing polyacrylamide gel electrophoresis. Specificity was determined by addition of p65 antibody (supershift) or unlabeled (cold) NF-B oligonucleotide to the nuclear extracts. Two separate experiments yielded similar results. Figure 8 . Effects of pyrrolidine dithiocarbamate on protein synthesis induced by mechanical strain. NRVM were subjected to 0% (open bar) or 4% cyclic mechanical strain (closed bars) in the presence or absence of pyrrolidine dithiocarbamate (10 to 100 mol/L) with 1.0 mCi/mL [ 3 H]leucine for 24 hours. Pyrrolidine dithiocarbamate were applied to myocytes 30 minutes before experiments. Protein synthesis results are expressed as relative cpm/dish standardized to mean cpm of control cells in each experiment. Bar graphs with error bars represent meanϮSD (nϭ4). *PϽ0.01 vs control; †PϽ0.05 vs exposed to strain.
